Senior Director
Waters Corporation
Matt Lauber is a seasoned bioseparations expert and a portfolio leader for a group within Waters that is responsible for developing and commercially supporting new LC-based analytical approaches, chromatography columns, reagents and enzymes for the analysis of gene and cell therapy drug products. He has been a leading inventor at Waters, published over 50 research articles on LC-based techniques, and has previously helped bring several exciting new analytical technologies to market, ranging from rapid N-glycan analysis to low adsorption surfaces and novel, high resolution stationary phases. Matt is also a key member of a number of scientific initiatives at Waters and an ever-enthusiastic supporter to global collaborations and audacious goals.